[1] A. L. Lehninger, D. L. Nelson, M. M. Cox, Principles of Biochemistry, Worth Publishers, New York (1993).

[2] B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, P. Walter, Molecular Biology of the Cell, Garland Science, New York (2002).

[3] C. D. Berdanier, Mitochondria in Health and Disease, Taylor & Francis, New York (2005).

[4] J. S. Modica-Napolitano, M. Kulawiec, K. K. Singh, “Mitochondria and human cancer,” Curr. Mol. Med. 7, 121–131 (2007).

[5] H. K. Lee, “Mitochondria in diabetes mellitus,” in Mitochondria in Health and Disease, C. D. Berdanier, Eds., pp. 377–454, Taylor & Francis, New York (2005).

[6] R. S. Balaban, S. Nemoto, T. Finkel, “Mitochondria, oxidants, and aging,” Cell 120, 483–495 (2005).

[7] D. C. Wallace, “Mitochondrial diseases in man and mouse,” Science 283, 1482–1488 (1999).

[8] S. Grandemange, S. Herzig, J. C. Martinou, “Mitochondrial dynamics and cancer,” Semin. Cancer Biol. 19, 50–56 (2009).

[9] C. Frezza, E. Gottlieb, “Mitochondria in cancer: Not just innocent bystanders,” Semin. Cancer Biol. 19, 4–11 (2009).

[10] A. K. Holley, D. K. St Clair, “Watching the watcher: Regulation of p53 by mitochondria,” Future Oncol. 5, 117–130 (2009).

[11] D. A. Tennant, R. V. Duran, H. Boulahbel, E. Gottlieb, “Metabolic transformation in cancer,” Carcinogenesis 30, 1269–1280 (2009).

[12] F. Koch-Nolte, F. Haag, A. H. Guse, F. Lund, M. Ziegler, “Emerging roles of NAD+ and its metabolites in cell signaling,” Sci. Signal. 2, mr1 (2009).

[13] R. Banerjee, Redox Biochemistry, John Wiley & Sons, Hoboken, New Jersey (2008).

[14] B. Chance, G. R. Williams, “Respiratory enzymes in oxidative phosphorylation. 4. The respiratory chain,” J. Biol. Chem. 217, 429–438 (1955).

[15] B. Chance, G. R. Williams, “A method for the localization of sites for oxidative phosphorylation,” Nature 176, 250–254 (1955).

[16] B. Chance, H. Baltscheffsky, “Respiratory enzymes in oxidative phosphorylation. 7. Binding of intramitochondrial reduced pyridine nucleotide,” J. Biol. Chem. 233, 736–739 (1958).

[17] B. Chance, “Pyridine nucleotide as an indicator of the oxygen requirements for energy-linked functions of mitochondria,” Circ. Res. 38, I31–38 (1976).

[18] B. Chance, P. Cohen, F. Jobsis, B. Schoener, “Intracellular oxidation-reduction states in vivo,” Science 137, 499–508 (1962).

[19] B. Chance, “Spectrophotometric and kinetic studies of flavoproteins in tissues, cell suspensions, mitochondria and their fragments,” in Flavins and Flavoproteins, E. C. Slater, Ed., pp. 498–510, Elsevier, Amsterdam (1966).

[20] B. Chance, P. Cohen, F. Jobsis, B. Schoener, “Localized fluorometry of oxidation-reduction states of intracellular pyridine nucleotide in brain and kidney cortex of the anesthetized rat,” Science 136, 325 (1962).

[21] I. Hassinen, B. Chance, “Oxidation-reduction properties of the mitochondrial flavoprotein chain,” Biochem. Biophys. Res. Commun. 31, 895–900 (1968).

[22] B. Chance, B. Schoener, R. Oshino, F. Itshak, Y. Nakase, “Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals,” J. Biol. Chem. 254, 4764–4771 (1979).

[23] B. Chance, N. Oshino, T. Sugano, A. Mayevsky, “Basic principles of tissue oxygen determination from mitochondrial signals,” Adv. Exp. Med. Biol. 37A, 277–292 (1973).

[24] B. Chance, “Optical method,” Ann. Rev. Biophys. Biophys. Chem. 20, 1–28 (1991).

[25] B. Quistorff, J. C. Haselgrove, B. Chance, “High resolution readout of 3-D metabolic organ structure: An automated, low-temperature redox ratioscanning instrument,” Anal. Biochem. 148, 389–400 (1985).

[26] Y. Gu, Z. Qian, J. Chen, D. Blessington, N. Ramanujam, B. Chance, “High-resolution threedimensional scanning optical image system for intrinsic and extrinsic contrast agents in tissue,” Rev. Sci. Instrum. 73, 172–178 (2002).

[27] B. Chance, B. Schoener, “Fluorometric studies of flavin component of the respiratory chain,” in Flavins and Flavoproteins, E. C. Slater, Ed., pp. 510–519, Elsevier, Amsterdam (1966).

[28] L. Z. Li, R. Zhou, H. N. Xu, L. Moon, T. X. Zhong, E. J. Kim, H. Qiao, R. Reddy, D. Leeper, B. Chance, J. D. Glickson, “Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential,” Proc. Nat. Acad. Sci. U.S.A. 106, 6608–6613 (2009).

[29] R. L. Veech, “The determination of the redox states and phosphorylation potential in living tissues and their relationship to metabolic control of disease phenotypes,” Biochem. Mol. Biol. Educ. 34, 168– 179 (2006).

[30] K. Ozawa, B. Chance, A. Tanaka, S. Iwata, T. Kitai, I. Ikai, “Linear correlation between acetoacetate beta-hydroxybutyrate in arterial blood and oxidized flavoprotein reduced pyridine-nucleotide in freeze-trapped human liver-tissue,” Biochimica Et Biophysica Acta 1138, 350–352 (1992).

[31] P. C. Nowell, “Clonal evolution of tumor-cell populations,” Science 194, 23–28 (1976).

[32] I. J. Fidler, M. L. Kripke, “Metastasis results from preexisting variant cells within a malignant-tumor,” Science 197, 893–895 (1977).

[33] I. J. Fidler, I. R. Hart, “Biological diversity in metastatic neoplasms — origins and implications,” Science 217, 998–1003 (1982).

[34] L. Z. Li, R. Zhou, T. Zhong, L. Moon, E. J. Kim, H. Qiao, S. Pickup, M. J. Hendrix, D. Leeper, B. Chance, J. D. Glickson, “Predicting melanoma metastatic potential by optical and magnetic resonance imaging,” Adv. Exp. Med. Biol. 599, 67–78 (2007).

[35] H. N. Xu, R. Zhou, S. Nioka, B. Chance, J. D. Glickson, L. Z. Li, “Histological basis of MR/optical imaging of human melanoma mouse xenografts spanning a range of metastatic potentials,” Adv. Exp. Med. Biol. 645, 247–253 (2009).

[36] E. M. C. Hillman, “Optical brain imaging in vivo: Techniques and applications from animal to man,” J. Biomed. Opt. 12, 051402 (2007).

[37] A. Mayevsky, B. Chance, “Oxidation-reduction states of NADH in vivo: From animals to clinical use,” Mitochondrion 7, 330–339 (2007).

[38] K. Shibuki, R. Hishida, H. Murakami, M. Kudoh, T. Kawaguchi, M. Watanabe, S. Watanabe, T. Kouuchi, R. Tanaka, “Dynamic imaging of somatosensory cortical activity in the rat visualized by flavoprotein autofluorescence,” J. Physiol. Lond. 549: 919–927 (2003).

[39] B. Weber, C. Burger, M. T. Wyss, G. K. von Schulthess, F. Scheffold, A. Buck, “Optical imaging of the spatiotemporal dynamics of cerebral blood flow and oxidative metabolism in the rat barrel cortex,” Eur. J. Neurosci. 20, 2664–2670 (2004).

[40] Y. Yuan, Y. F. Li, B. D. Cameron, P. Relue, “Fluorescence anisotropy of cellular NADH as a tool to study different metabolic properties of human melanocytes and melanoma cells,” IEEE J. Sel. Top Quant. Electron. 13, 1671–1679 (2007).

[41] H. N. Xu, B. Wu, S. Nioka, B. Chance, L. Z. Li, “Calibration of redox scanning for tissue samples,” in Optical Tomography and Spectroscopy of Tissue VIII, 71742F-8, SPIE, San Jose, CA, USA, (2009).

[42] H. N. Xu, B. Wu, S. Nioka, B. Chance, L. Z. Li, “Calibration of CCD-based redox imaging for biological tissues,” in Medical Imaging 2009: Biomedical Applications in Molecular, Structural, and Functional Imaging, 72622F-7, SPIE, Lake Buena Vista, FL, USA, (2009).

[43] A. K. Ghosh, D. Finegold, W. White, K. Zawalich, F. M. Matschinsky, “Quantitative histochemical resolution of the oxidation-reduction and phosphate potentials within the simple hepatic acinus,” J. Biol. Chem. 257, 5476–5481 (1982).

[44] M. Ranji, S. Nioka, H. N. Xu, B. Wu, L. Z. Li, D. L. Jaggard, B. Chance, “Fluorescent images of mitochondrial redox states in in situ mouse hypoxic ischemic intestines,” J. Innov. Opt. Health Sci. 2(4), 365–374 (2009).

[45] A. Mayevsky, G. G. Rogatsky, “Mitochondrial function in vivo evaluated by NADH fluorescence: From animal models to human studies,” Am. J. Physiol. Cell. Physiol. 292, C615–640 (2007).

[46] A. Mayevsky, “Shedding light on life: Optical assessment of mitochondrial function and tissue vitality in biology and medicine,” J. Innov. Opt. Health Sci. 1, 71–83 (2008).

[47] K. C. Reinert, R. L. Dunbar, W. Gao, G. Chen, T. J. Ebner, “Flavoprotein autofluorescence imaging of neuronal activation in the cerebellar cortex in vivo,” J. Neurophysiol. 92, 199–211 (2004).

[48] S. Zhuo, J. Chen, T. Luo, X. Jiang, S. Xie, R. Chen, “Two-layered multiphoton microscopic imaging of cervical tissue,” Lasers Med. Sci. 24, 359–363 (2009).

[49] L. M. Tiede, S. M. Rocha-Sanchez, R. Hallworth, M. G. Nichols, K. Beisel, “Determination of hair cell metabolic state in isolated cochlear preparations by two-photon microscopy,” J. Biomed. Opt. 12, 021004 (2007).

[50] M. C. Skala, K.M. Riching, A. Gendron-Fitzpatrick, J. Eickhoff,K.W. Eliceiri, J. G. White, N. Ramanujam, “In vivo multiphoton microscopy of NADH and FAD redox states, fluorescence lifetimes, and cellular morphology in precancerous epithelia,” Proc. Natl. Acad. Sci. U.S.A. 104, 19494–19499 (2007).

[51] S. Zhuo, J. Chen, N. Cao, X. Jiang, S. Xie, S. Xiong, “Imaging collagen remodeling and sensing transplanted autologous fibroblast metabolism in mouse dermis using multimode nonlinear optical imaging,” Phys. Med. Biol. 53, 3317–3325 (2008).

[52] J. G. Lyubovitsky, J. A. Spencer, T. B. Krasieva, B. Andersen, B. J. Tromberg, “Imaging corneal pathology in a transgenic mouse model using nonlinear microscopy,” J. Biomed. Opt. 11, 014013 (2006).

[53] Z. H. Zhang, H. Li, Q. Liu, L. L. Zhou, M. Zhang, Q. M. Luo, J. Glickson, B. Chance, G. Zheng, “Metabolic imaging of tumors using intrinsic and extrinsic fluorescent markers,” Biosens. Bioelectr. 20, 643–650 (2004).

[54] D. R. Welch, J. E. Bisi, B. E. Miller, D. Conaway, E. A. Seftor, K. H. Yohem, L. B. Gilmore, R. E. Seftor, M. Nakajima, M. J. Hendrix, “Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line,” Int. J. Cancer 47, 227–237 (1991).

[55] J. M. Kozlowski, I. R. Hart, I. J. Fidler, N. Hanna, “A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice,” J. Nat. Cancer Inst. 72, 913–917 (1984).

[56] N. Ramanujam, R. Richards-Kortum, S. Thomsen, A. Mahadevan-Jansen, M. Follen, B. Chance, “Low temperature fluorescence imaging of freeze-trapped human cervical tissues,” Opt. Express 8, 335–343 (2001).

[57] Z. Zhang, D. Blessington, H. Li, T. M. Busch, J. Glickson, Q. Luo, B. Chance, G. Zheng, “Redox ratio of mitochondria as an indicator for the response of photodynamic therapy,” J. Biomed. Opt. 9, 772–778 (2004).

[58] C. H. Contag, “In vivo pathology: Seeing with molecular specificity and cellular resolution in the living body,” Ann. Rev. Pathol. 2, 277–305 (2007).

[59] R. Cicchi, L. Sacconi, A. Jasaitis, R. P. O’Connor, D. Massi, S. Sestini, V. De Giorgi, T. Lotti, F. S. Pavone, “Multidimensional custom-made non-linear microscope: From ex-vivo to in-vivo imaging,” Appl. Phys. B Lasers Opt. 92, 359–365 (2008).

[60] K. Konig, A. Ehlers, I. Riemann, S. Schenkl, R. Buckle, M. Kaatz, “Clinical two-photon microendoscopy,” Microsc. Res. Tech. 70, 398–402 (2007).

[61] H. C. Bao, J. Allen, R. Pattie, R. Vance, M. Gu, “Fast handheld two-photon fluorescence microendoscope with a 475 microm × 475 microm field of view for in vivo imaging,” Opt. Lett. 33, 1333–1335 (2008).

[62] C. T. Dooley, T. M. Dore, G. T. Hanson, W. C. Jackson, S. J. Remington, R. Y. Tsien, “Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators,” J. Biol. Chem. 279, 22284–22293 (2004).

[63] J. V. Rocheleau, W. S. Head, D. W. Piston, “Quantitative NAD(P)H/flavoprotein autofluorescence imaging reveals metabolic mechanisms of pancreatic islet pyruvate response,” J. Biol. Chem. 279, 31780–31787 (2004).

[64] M. G. Nichols, E. E. Barth, J. A. Nichols, “Reduction in DNA synthesis during two-photon microscopy of intrinsic reduced nicotinamide adenine Dinucleotide Fluorescence,” Photochem. Photobiol. 81, 259–269 (2005).

[65] B. Zelent, T. Troxler, J. M. Vanderkooi, “Temperature dependence for fluorescence of β-NADH in glycerol/ water solution and in trehalose/sucrose glass,” J. Fluorescence 17, 37–42 (2007).

[66] H. N. Xu, B. Wu, S. Nioka, B. Chance, L. Z. Li, “Quantitative redox scanning of tissue samples using a calibration procedure,” J. Innov. Opt. Health Sci. 2, 375–385 (2009).